Brief: Longeveron Announces Publication Of Final Data From Elpis I Trial Of Lomecel-Btm For Hypoplastic Left Heart Syndrome In Peer-Reviewed Journal

Longeveron

19/01/2023 13:48

Jan 19 (Reuters) - Longeveron Inc  LGVN.O :
    * LONGEVERON ANNOUNCES PUBLICATION OF FINAL DATA FROM ELPIS
I
TRIAL OF LOMECEL-BTM FOR HYPOPLASTIC LEFT HEART SYNDROME IN
PEER-REVIEWED JOURNAL
    * LONGEVERON INC - STUDY MET PRIMARY SAFETY ENDPOINT
    * LONGEVERON INC - ALL PATIENTS ALIVE, TRANSPLANT-FREE, AND
MAINTAINED EXPECTED RATE OF GROWTH ONE YEAR AFTER TREATMENT
    * LONGEVERON INC - DATA SUPPORTS ONGOING CLINICAL
DEVELOPMENT OF
LOMECEL-B(TM) FOR HLHS, CURRENTLY BEING EVALUATED IN A PHASE 2A
TRIAL

Source text for Eikon:  ID:nGNX1y3VVT 
Further company coverage:  LGVN.O 
 ((Reuters.Briefs@thomsonreuters.com;))